Simplify Medical, Inc.

15 articles about Simplify Medical, Inc.

• Simplify Medical to Present at the 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum

  11/16/2020

  Simplify Medical, Inc., maker of the Simplify® Cervical Artificial Disc, announced that David Hovda, President and Chief Executive Officer, will present at the 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum and invites investors to participate via the conference webcast.

• Simplify Medical Completes PMA Submission for 2-Level Simplify Disc IDE StudyBuilds on recent 1-Level PMA Approval

  10/29/2020

  Simplify Medical, Inc., maker of the Simplify® Cervical Artificial Disc, announced today the completion of the Pre-Market Approval (PMA) submission for the 2-level Simplify Disc IDE Study to the U.S. Food and Drug Administration (FDA

• Simplify Medical Completes PMA Submission for 1-Level Simplify Disc IDE StudyFDA Determined PMA is Complete and is Commencing Filing Review 

  4/21/2020

  Simplify Medical Pty Ltd., maker of the Simplify® cervical artificial disc, announced the completion of the Pre-Market Approval submission for the 1-level Simplify Disc IDE Study to the U.S. Food and Drug Administration.

• Simplify Medical Selected to Present Two Podium Presentations at the 20th ISASS Annual ConferenceCompany nominated for the “Best of Awards” to be selected by conference attendees during the closing ceremonies

  2/20/2020

  Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, announced the International Society for the Advancement of Spine Surgery has selected two abstracts on the Simplify Disc for podium presentations at the 20th Annual Conference.

• Simplify Medical Announces Oral Presentation at NASS 2019 Annual Meeting

  9/17/2019

  Simplify Medical Pty Ltd. announced that data from three sites in the Company’s single-level Investigational Device Exemption (IDE) clinical trial evaluating the Simplify® Disc for total cervical disc replacement was selected as a Podium Presentation during the 2019 North American Spine Society (NASS) Annual Meeting, being held September 25-28 in Chicago, IL.

• Simplify Medical Completes Enrollment in U.S. IDE Pivotal Trial of Simplify® Disc for Two-Level Cervical Disc Replacement

  11/14/2018

  The Simplify Disc is designed for biomechanical motion, anatomical height-matching, and MRI compatibility with a goal of simplifying the treatment of degenerative disc disease.

• 

  BioSpace Movers and Shakers - Oct. 22

  10/22/2018

  Execs at Novo Nordisk, AbbVie, and more made moves this week. Here's a roundup of those changes.

• Simplify Medical Appoints IP Attorney Veteran to VP, General Counsel

  10/18/2018

  Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, today announced that it has appointed Cindy Lynch to Vice President, General Counsel. Ms. Lynch has nearly 15 years of experience providing strategic legal and intellectual property advice to medical device startups.

• Simplify® Medical Technology Selected for Innovative Technology Paper at NASS 2018 Annual Meeting

  9/17/2018

  Company to feature Simplify™ Disc at Booth #1911

• Simplify Medical Announces 50th U.S. Patent for Innovative Cervical Disc Replacement Portfolio

  2/27/2018

  . The Simplify Disc is designed to minimize patient risk associated with radiation, optimize long-term durability, simplify implantation and increase access to cervical disc replacement for patients with smaller anatomies.

• Simplify Medical Completes Enrollment in IDE Trial Studying Simplify Disc in One Level of Spine for Cervical Disc Replacement

  2/14/2018

  Simplify Medical today announced completion of enrollment in its U.S. IDE trial studying the Simplify Disc used for one-level cervical implantation of the device between C3 to C7 compared with a historical control group.

• 

  Simplify Medical Scores $23.25 Million in Second Tranche of Series B Financing

  2/9/2018

  Series B funds will be used to complete two ongoing U.S. pivotal clinical trials of the Simplify Disc studying its use in one level of the spine and in two adjacent levels of the spine as a treatment for cervical degenerative disc disease, and for commercialization outside of the U.S.

• Simplify Medical Banks $21 Million to Support Innovative Cervical Artificial Disc

  7/19/2017

• Simplify Medical, Inc. Announces First Patient Treated In U.S. Pivotal Trial Of MRI-Optimized Simplify Cervical Artifical Spinal Disc Used At Two Adjacent Levels

  4/12/2017

• Simplify Medical, Inc. Release: Study Finds Wide Use Of Computed Tomography (CT) For Post-Operative Assessment Of Spine Surgery, Despite Radiation Risks For Patients

  3/8/2017